Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5
Condition(s):MDS; AMLLast Updated:April 27, 2012Completed
Hide Studies Not Open or Pending
Condition(s):MDS; AMLLast Updated:April 27, 2012Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:August 17, 2018Completed
Condition(s):LeukemiaLast Updated:April 16, 2020Completed
Condition(s):Uveal MelanomaLast Updated:December 2, 2022Active, not recruiting
Condition(s):Chromosome 9P Deletion Syndrome; 9p Minus Syndrome; Alfi Syndrome; 9P Monosomy; 9P Partial Monosomy SyndromeLast Updated:May 25, 2023Recruiting
Condition(s):Myelodysplastic Syndromes; Acute Myelogenous LeukemiaLast Updated:September 27, 2013Terminated
Condition(s):Trisomy 21; Trisomy 18; Trisomy 13; Monosomy XLast Updated:February 22, 2018Completed
Condition(s):AMLLast Updated:April 7, 2014Terminated
Condition(s):Hematologic Malignancy; Acute Leukemia; Remission; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; AML; TP53; Intrachromosomal Amplification of Chromosome 21; Cytogenetic Abnormality; CNS Leukemia; Minimal Residual Disease; Myelodysplasia; Juvenile Myelomonocytic Leukemia; Somatic Mutation; PTPN11 Gene Mutation; N-RAS Gene Amplification; Neurofibromatosis 1; NF1 Mutation; CBL Gene Mutation; Monosomy 7; Chromosome Abnormality; Fetal HemoglobinLast Updated:October 3, 2023Recruiting
Condition(s):22q11 Deletion Syndrome; DiGeorge Syndrome; Trisomy 21; Trisomy 18; Trisomy 13; Monosomy X; Sex Chromosome Abnormalities; Cri-du-Chat Syndrome; Angelman Syndrome; Prader-Willi Syndrome; 1p36 Deletion SyndromeLast Updated:January 29, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.